INVO Bioscience, Inc. (INVO)
|Net Income (ttm)||-5.30M|
|Trading Day||January 22|
|Day's Range||3.02 - 3.12|
|52-Week Range||2.98 - 3.42|
There are no news available yet.
INVO Bioscience, a medical device company, provides assisted reproductive technology solutions worldwide. The company offers INVOcell, a patented intravaginal culture system used for the natural in vivo incubation of eggs and sperm during fertilization and early embryo development; and INVOcell Retention device, a single-use modified diaphragm that includes holes to allow for natural drainage of vaginal fluids to aid in retention of the INVOcell device in the vaginal cavity during the incubation period. It also provides fixed laboratory equipme... [Read more...]
Steven M. Shum
|Stock Exchange |
|Ticker Symbol |
In 2019, INVO's revenue was $1.48 million, an increase of 199.41% compared to the previous year's $494,375. Losses were -$2.17 million, -29.54% less than in 2018.
According to 2 analysts, the average rating for INVO stock is "Buy." The 12-month stock price forecast is 5.38, which is an increase of 73.27% from the latest price.